Barings LLC Incyte Corp Transaction History

Barings LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $468,565 - $604,172	-5,508 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $62,674 - $85,282	-992 Reduced 15.26%	5,508 $403,000
Q2 2019 Aug 12, 2019	SELL	$73.52 - $88.7 $867,536 - $1.05 Million	-11,800 Reduced 64.48%	6,500 $552,000
Q1 2019 May 08, 2019	BUY	$63.56 - $88.17 $1.16 Million - $1.61 Million	18,300 New	18,300 $1.57 Million

629

198M

766K

476K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

Stay updated on Barings LLC with notifications on news.